Committee backs statute update to allow nasal epinephrine in schools; parents and nurses seek broader language for glucose monitoring

Representative Josh Wheeler introduced House Bill 531 to modernize statute to permit single-dose epinephrine delivery systems used in schools, explaining that technology has advanced and intranasal sprays can provide equivalent dosing without needles.

"The nasal spray is a much more comfortable delivery system," Wheeler said, and he argued the change will reduce hesitation to administer life-saving medication. Brittany Shipley, a parent, supported the bill but asked the committee to amend the language on page 1, line 20 so blood-glucose monitoring is allowed when prescribed by a licensed provider for medical necessity rather than being tied solely to a diabetes diagnosis. Shipley said diagnosis-specific statutory language creates confusion and delays when a pupil requires monitoring for other medical reasons.

Alicia Jordan, a registered school nurse, said staff sometimes hesitate to use auto-injectors because of needle fear and endorsed allowing all automatic dosing delivery systems, including intranasal and other emerging formulations. She said permitting alternative routes would reduce delays in care. Alexis Morgan, Idaho PTA director of public policy, told the committee intranasal epinephrine is available free to K–12 schools through the NEFE in Schools program and requested a due-pass recommendation.

Representative Wheeler offered to work with Shipley and Representative Leavitt on a separate bill to address the blood-glucose monitoring concern if committee members preferred not to amend HB 531 in general orders. The committee voted to send House Bill 531 to the floor with a due-pass recommendation; the motion carried.